Molekule, the leader in reinventing air purification, announced today that professional basketball player Kevin Love has invested in the company to support its technological advances in air quality. The company is the pioneer of Photo Electrochemical Oxidation (PECO) air purification devices, including Air Mini, Air Mini+, and Air Pro which were recently granted FDA clearance as medical devices for the destruction of viruses and bacteria.

With more than $100 million in funding, most recently via a Series C financing round completed in early 2020, Molekule welcomes Love as an investor in addition to its support from RPS Ventures, Founders Circle Capital, Foundry Group, Crosslink Capital, Uncork Capital, TransLink Capital, and Inventec Appliances Corp (IAC).

Molekule is on a mission to provide clean indoor air to everyone, everywhere. Based on 25 years of research and development, the company's patented photo electrochemical oxidation (PECO) technology destroys the widest range of pollutants, including VOCs, mold, bacteria, viruses, and allergens, when compared to conventional filters. Molekule's range of air purification solutions have been reviewed and validated by third-party laboratories, as well as continual internal testing, and its medical-grade products have been granted medical device clearance by the FDA.